top of page


NICE backs Padcev and Keytruda combination around surgery for muscle-invasive bladder cancer
NICE has issued positive final draft guidance for perioperative Padcev and Keytruda in muscle-invasive bladder cancer, potentially expanding NHS treatment access before and after surgery for eligible patients regardless of cisplatin suitability.

nuaxia
5 days ago2 min read


Scotland backs UCB's Zilbrysq while NICE appraisal in England remains unresolved
The differing reimbursement positions highlight how health technology assessment decisions can diverge across UK nations, affecting the timing of patient access to new medicines.

nuaxia
Aug 132 min read
bottom of page